This page shows the latest treatment news and features for those working in and with pharma, biotech and healthcare.
Both children died after corticosteroid medicines – which were used to reduce the risk of side effects after treatment – began to be tapered off. ... Zolgensma is currently administered intravenously, meaning treatment is limited to younger children
AMR occurs when bacteria, viruses, fungi and parasites change over time and no longer respond to drug treatments, making infections harder to treat and increasing the risk of severe illness and
Evusheld – tixagevimab co-packaged with cilgavimab – is a preventative treatment that is given before people have been exposed to the virus.
RLT is an emerging treatment option that has the potential to offer an alternative treatment pathway for some cancer patients. ... There continues to be a real and pressing need for better treatments for people with advanced prostate cancer.
There are treatment options available for those diagnosed with stage 3 NSCLC, however if a patient progresses to stage 4 – otherwise known as metastatic cancer – the options available are often limited ... time of diagnosis to ensure patients receive
The approval is specifically for the treatment of acute, uncomplicated influenza in otherwise healthy children aged five to less than 12 years of age who have been symptomatic for no more ... well as adolescents, and we are pleased to now offer
More from news
Approximately 25 fully matching, plus 5,513 partially matching documents found.
through inefficient use of raw materials, unnecessary use of energy and water, or waste treatment – and this figure can be as high as 10%.
Patients are now more involved in their treatment decisions, in partnership with their clinician. ... focus on itch, pain and symptom severity as measured by the patient in the treatment of psoriasis.
By working alongside small, dynamic companies we can enable fresh ideas which improve the health of patients and society through the optimisation of existing treatments and technologies. ... treatment and rehabilitation.
While other sectors were plunged into chaos, COVID-19 highlighted our industry’s remarkable capacity for innovation, with new vaccines and treatments being developed, tested and approved in record time. ... Why, as an industry, are we incredibly
State clearly what the ingredients and other associations of the treatments are, and you’ll win the trust and confidence of the audience.
More from intelligence
Approximately 3 fully matching, plus 776 partially matching documents found.
Gillis joined VMLY&R in 2020 to launch a specialist international agency, focusing on prescription pharma companies developing breakthrough treatments.
First launched in 2012, the 100, 000 Genome Project had ambitious plans to map the genomes of NHS patients to deliver treatments for those with rare inherited diseases and cancer.
This includes PARP inhibitor Lynparza (olaparib), third-generation tyrosine kinase inhibitor (TKI) Tagrisso (osimertinib), the recently approved MET inhibitor Orpathys (savolitinib) and Koselugo (selumetinib) – indicated for the treatment of
Their years of dedicated work on mRNA therapeutics positions CureVac well for bringing future treatments across a variety of indications to different patient populations.
The AMR Action Fund is an initiative created to bring two to four new antibiotics to patients by 2030 – treatments which are urgently needed to address the rapid rise of antibiotic
More from appointments
Approximately 0 fully matching, plus 225 partially matching documents found.
open up the conversation, encouraging women to demand better access to care and treatment, rather than suffer in silence. ... Furthermore, 69% agreed there should be more treatments available for the symptoms of menopause.
with promoting earlier diagnosis and access to novel treatments.
Children can be left facing an uncertain future and an unclear treatment pathway when they have a rare disorder. ... Numerous unknown disorders have been identified with clarity, finally providing diagnosis and treatment options to thousands.
Giving patients a voice when considering their treatment options is something we care about deeply. ... Understanding and cooperative treatment plans will improve the efficacy of administration to those with mental health difficulties.
treatment of rare diseases.” said Dorothy at the end of her second day with us.
More from PMHub
Approximately 29 fully matching, plus 674 partially matching documents found.
REACH, ENGAGE & MEASURE HCPs ONLINE - Accomplish meaningful engagement via Medthority (www.medthority.com), a trusted independent medical website. Support the...